Advertisement
Screener

Neurogene Inc. (NGNE) Prepaid Expense, Current

2.8 / 5 stars · 68/120 Roast Me

Neurogene Inc. Prepaid Expense, Current

Neurogene Inc. (NGNE) had Prepaid Expense, Current of $2.56 million as of 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Balance Sheet › Assets › Assets, Current

us-gaap:PrepaidExpenseCurrent · last filed 2026-08-11

  • 2026-06-30: Prepaid Expense, Current $2.56M.
  • 2026-03-31: Prepaid Expense, Current $2.94M.
  • 2025-12-31: Prepaid Expense, Current $1.94M.
  • 2025-09-30: Prepaid Expense, Current $3.82M.
Period endPrepaid Expense, Current
2026-06-30$2.56M
10-Q · filed 2026-08-11
2026-03-31$2.94M
10-Q · filed 2026-05-12
2025-12-31$1.94M
10-Q · filed 2026-08-11
2025-09-30$3.82M
10-Q · filed 2025-11-13
2025-06-30$2.19M
10-Q · filed 2025-08-11
2025-03-31$2.20M
10-Q · filed 2025-05-09
2024-12-31$1.89M
10-K · filed 2026-03-24
2024-09-30$2.38M
10-Q · filed 2024-11-18
2024-06-30$3.07M
10-Q · filed 2024-08-09
2024-03-31$2.77M
10-Q · filed 2024-05-10
2023-12-31$1.50M
10-K · filed 2025-03-24
2022-12-31$1.08M
10-K · filed 2024-03-18
2014-09-30$283.85K
10-Q · filed 2014-11-04
2014-06-30$424.24K
10-Q · filed 2014-08-11
2014-03-31$547.81K
10-Q · filed 2014-05-13
2013-12-31$63.98K
10-Q · filed 2014-11-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
CorMedix Inc. (CRMD)United States$0.605B3.25
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
Monopar Therapeutics (MNPR)United States$0.598B-34.82
Altimmune, Inc. (ALT)United States$0.593B-6.43
ZEVRA THERAPEUTICS, INC. (ZVRA)United States$0.668B14.61
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76